A drug with the SMILES CC(C)n1c(N2CCN(CC(=O)Nc3ccc4c(c3)OCCO4)CC2)nc2ccccc21 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -65.418%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CC(C)n1c(N2CCN(CC(=O)Nc3ccc4c(c3)OCCO4)CC2)nc2ccccc21
CC(C)n1c(N2CCN(CC(=O)Nc3ccc4c(c3)OCCO4)CC2)nc2ccccc21
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(1-propan-2-ylbenzimidazol-2-yl)piperazin-1-yl]acetamide